Clinical Trial

A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study aims to investigate the efficacy and safety of HRS-2129 in Chinese diabetic peripheral neuropathic pain (DPNP) in comparison to placebo.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-16
Trial Details
NCT Number NCT07377721
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Diabetic Peripheral Neuropathic Pain
Enrollment 168 participants
Start Date 2026-03-24
Primary Completion 2026-09 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-04-15